Furthermore, given that the effects of 5-HT2C agonists also include weight loss and a reduction in reward-seeking behaviors, the use of compounds that enhance 5-HT2C signaling would also be clinically relevant for the treatment of obesity or to prevent relapse to drug abuse. Here, HTR2C is linked to obesity due to melanocortin 4 receptor deficiency.